首页> 外文期刊>European Journal of Pharmacology: An International Journal >Long-lasting physiological antagonism of calcitonin gene-related peptide towards endothelin-1 in rat mesenteric arteries and human coronary arteries
【24h】

Long-lasting physiological antagonism of calcitonin gene-related peptide towards endothelin-1 in rat mesenteric arteries and human coronary arteries

机译:转析素基因相关肽对大鼠肠系膜动脉和人冠状动脉的内皮素-1的长持久的生理拮抗作用

获取原文
获取原文并翻译 | 示例
           

摘要

Endothelin-1 causes long-lasting contraction via endothelin type A receptor (ETAR) in isolated rat mesenteric arteries (RMA) that cannot be readily terminated by removing the agonist, or by adding the ETAR antagonist BQ123 or the NO donor sodium nitroprusside. It could be terminated by adding calcitonin-gene related peptide (CGRP), most likely because CGRP causes ET-1/ETAR dissociation. Here we investigated this phenomenon in human coronary microarteries (HCMA). We simultaneously verified the effects of CGRP in RMA and HCMA towards other vasoconstrictors, i.e., the α1- adrenoceptor agonist phenylephrine, the thromboxane A2 analog U46619 (9,11-dideoxy-11α,9α-epoxy-methano-prostaglandin F 2α) and KCl. Long-lasting contraction (remaining after washing away the agonist) was observed for ET-1 in RMA, but not HCMA. Constrictions to phenylephrine, U46619 or KCl did not last upon washing. When added on top of ET-1-initiated contraction in RMA, CGRP effectively counteracted vasoconstriction, i.e., it caused full relaxation. Inhibitory effects of CGRP were also observed when briefly exposing RMA and HCMA to CGRP 1 h before the addition of ET-1. Similar inhibitory effects of transient CGRP pre-incubation were seen towards phenylephrine, U46619 or KCl in RMA and HCMA. In conclusion, our data imply that CGRP, like ET-1, causes long-lasting effects that remain apparent up to 1 h after its removal from the organ bath. Thus, in addition to the reported dissociation of ET-1/ETAR complexes, CGRP causes long-lasting non-selective arterial smooth muscle relaxation that may add to the neuropeptide being a physiological antagonist of arterial effects of ET-1. Long-lasting, washout-resistant ET-1/ETAR interaction does not occur in HCMAs.
机译:内皮素-1通过内皮素造成长期收缩,通过除去激动剂,或通过加入ETAR拮抗剂BQ123或NO供体亚硝酸钠不能容易地终止于不能容易地终止的受体(ETAR)。可以通过添加降钙素 - 基因相关肽(CGRP)来终止,最有可能因为CGRP导致ET-1 / ETAR解离。在这里,我们研究了人冠状动脉微观(HCMA)中的这种现象。我们同时验证了CGRP在RMA和HCMA朝向其他血管收缩剂的影响,即α1-肾上腺素受体激动剂吩苯肾上腺素,硫脲A2类似物U46619(9,11-二佐氧-11α,9α-环氧 - 甲烷 - 前列腺素F2α)和KCl 。在RMA中的ET-1观察到持久的收缩(在洗涤播放后剩余的溶剂),但不是HCMA。对苯妥的收缩,U46619或KCL在洗涤后没有持续。当在RMA中的ET-1启动收缩的顶部添加时,CGRP有效地抵消了血管收缩,即,它引起了充分的放松。在添加ET-1之前将RMA和HCMA短暂暴露于CGRP 1 H时,还观察到CGRP的抑制作用。在RMA和HCMA中朝向苯妥,U46619或KCL看到瞬时CGRP预孵育的类似抑制作用。总之,我们的数据意味着CGRP,如ET-1,在从器官浴中移除后仍然明显最明显的效果。因此,除了报告的ET-1 / ETAR复合物的解离外,CGRP还会导致长期的非选择性动脉平滑肌松弛,这可能会增加神经肽是ET-1的动脉作用的生理拮抗剂。在HCMA中,不会发生耐久性的冲洗抗性ET-1 / ETAR相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号